Moreover, we suggest that the co-regulatory pattern of the five member genes of the TNFAIP1/POLDIP2 SFGM could originally be established as the result of epigenetic modifications and/or transcriptional activation rather than by recurrent amplification in breast cancer cells. The gene discussed is POLDIP2; the disease is breast carcinoma.